ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,365
-0,18%
Bitcoin
98 256,06
-0,05%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Zosano Pharma Corporation (ZSAN) Cours

Zosano Pharma Corporation

Zosano Pharma Corporation (ZSAN)

NASDAQ
0,5576
0,00
(0,00%)
À la fermeture: 06 Janvier 10:00PM
Retardé de 15 minutes
0,5576
0,00
( 0,00% )
Après les heures de négociation: -
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,5576
Prix Achat
0,535
Prix Vente
0,55
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,5576
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

ZSAN Dernières nouvelles

Plus de nouvelles

Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11

FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary...

02 Juin 2022
GlobeNewswire Inc.

Zosano Pharma Reports First Quarter 2022 Financial Results

FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter...

13 Mai 2022
GlobeNewswire Inc.

Zosano Pharma Provides Corporate Update

FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate update. On April 14, 2022...

29 Avril 2022
GlobeNewswire Inc.

Zosano Pharma Announces Reverse Stock Split Effective Today

FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its Board of Directors has approved...

11 Avril 2022
GlobeNewswire Inc.

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results

FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter...

17 Mars 2022
GlobeNewswire Inc.

Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced...

09 Février 2022
GlobeNewswire Inc.

Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten...

08 Février 2022
GlobeNewswire Inc.

CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose

FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- In a press release published under the same headline today by Zosano Pharma Corporation (Nasdaq:ZSAN), a measurement was incorrectly stated as...

05 Janvier 2022
GlobeNewswire Inc.

Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose

FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial...

05 Janvier 2022
GlobeNewswire Inc.

Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. Yang

FREMONT, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced changes to its board of directors...

13 Décembre 2021
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ZSAN - Frequently Asked Questions (FAQ)

What is the current Zosano Pharma share price?
The current share price of Zosano Pharma is US$ 0,5576
What is the 1 year trading range for Zosano Pharma share price?
Zosano Pharma has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
155,16k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
967,95k
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,4M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ZSAN
Zosano Pharma
ASX
TNY
Tinybeans
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés